Literature DB >> 30213454

Medical decision making for older patients during multidisciplinary oncology team meetings.

Sifra Bolle1, Ellen M A Smets2, Marije E Hamaker3, Eugène F Loos4, Julia C M van Weert5.   

Abstract

OBJECTIVES: Multidisciplinary team meetings aim to facilitate efficient and accurate communication surrounding the complex process of treatment decision making for older patients with cancer. This process is even more complicated for older (≥70 years) patients as the lack of empirical evidence on treatment regimens in patients with age-related problems such as comorbidity and polypharmacy, necessitates a patient-centred approach.This study investigates the decision making process for older patients with cancer during multidisciplinary team meetings and the extent to which geriatric evaluation and geriatric expertise contribute to this process.
METHODS: Non-participant observations of 171 cases (≥70 years) during 30 multidisciplinary team meetings in five hospitals and systematically analysed using a medical decision making framework. All cases were in patients with colon or rectal cancer.
RESULTS: First, not all steps from the medical decision making framework were followed. Second, we found limited use of patient-centred information such as (age-related) patient characteristics and patient preferences during the decision making process. Third, a geriatric perspective was largely missing in multidisciplinary team meetings.
CONCLUSIONS: This study uncovers gaps in the treatment decision making process for older patients with cancer during multidisciplinary team meetings. In particular individual vulnerabilities and patient wishes are often neglected.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aged; Clinical decision-making; Colorectal cancer; Geriatric assessment; Interdisciplinary communication; Multidisciplinary oncology team meeting; Patient-Centred care

Mesh:

Year:  2018        PMID: 30213454     DOI: 10.1016/j.jgo.2018.07.016

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN: 1879-4068            Impact factor:   3.599


  6 in total

1.  Medical and Nonmedical Information during Multidisciplinary Team Meetings in Cancer Care.

Authors:  Jessica Wihl; Linn Rosell; Tobias Carlsson; Sara Kinhult; Gert Lindell; Mef Nilbert
Journal:  Curr Oncol       Date:  2021-02-23       Impact factor: 3.677

2.  Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists.

Authors:  Kah Poh Loh; Maya Abdallah; Sindhuja Kadambi; Megan Wells; Anita J Kumar; Jason H Mendler; Jane L Liesveld; Marsha Wittink; Kristen O'Dwyer; Michael W Becker; Colin McHugh; Wendy Stock; Navneet S Majhail; Tanya M Wildes; Paul Duberstein; Supriya Gupta Mohile; Heidi D Klepin
Journal:  Leuk Lymphoma       Date:  2020-10-11

3.  Contributions to Multidisciplinary Team Meetings in Cancer Care: Predictors of Complete Case Information and Comprehensive Case Discussions.

Authors:  Jessica Wihl; Linn Rosell; Kirsten Frederiksen; Sara Kinhult; Gert Lindell; Mef Nilbert
Journal:  J Multidiscip Healthc       Date:  2021-09-04

4.  Adapting patients' oncological treatment through remote participation of general practitioners in multi-disciplinary consultation meetings: A feasibility study.

Authors:  Vladimir Druel; Laetitia Gimenez; Paul Tachousin; Nathalie Boussier; Eric Bauvin; Grosclaude Pascale; Odile Beyne-Rauzy; Marie-Eve Rougé Bugat
Journal:  Eur J Gen Pract       Date:  2022-12       Impact factor: 1.904

5.  Factors influencing the quality and functioning of oncological multidisciplinary team meetings: results of a systematic review.

Authors:  Janneke E W Walraven; Olga L van der Hel; J J M van der Hoeven; Valery E P P Lemmens; Rob H A Verhoeven; Ingrid M E Desar
Journal:  BMC Health Serv Res       Date:  2022-06-27       Impact factor: 2.908

6.  Current Treatment Approaches and Outcomes in the Management of Rectal Cancer Above the Age of 80.

Authors:  Ali P Mourad; Marie Shella De Robles; Soni Putnis; Robert D R Winn
Journal:  Curr Oncol       Date:  2021-03-30       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.